Lucentis (Roche)

Lucentis (ranibizumab) is a medication developed by Roche, primarily used to treat certain eye conditions, such as age-related macular degeneration (AMD) and diabetic macular edema. These conditions can cause vision loss due to abnormal blood vessel growth in the retina. Lucentis works by blocking a protein called VEGF, which contributes to this growth. By inhibiting VEGF, Lucentis helps reduce swelling and maintain or improve vision. It is usually administered as an injection into the eye by a healthcare professional. Regular treatments can help manage symptoms and prevent further vision deterioration.